21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
82.92.Z - Packaging activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 12,5 | 12,7 | 15 | 18 |
EBITDA | 13,1 | 13,2 | 15 | 13,3 |
Short time liabilities | 5,7 | 6,1 | 6 | -2 |
Equity capital | 27,7 | 37,2 | 48,4 | 30,3 |
Operating profit (EBIT) | 12,5 | 12,6 | 14,1 | 12 |
Assets | 35,5 | 45,3 | 56,7 | 25,1 |
Net profit (loss) | 10,2 | 10,3 | 12,2 | 18,1 |
Cash | 14,1 | 20,3 | 27,4 | 35 |
Liabilities and provisions for liabilities | 7,8 | 8,1 | 8,2 | 1,3 |
Net income from sale | 36,7 | 42,6 | 48,2 | 13,1 |
Working assets | 30,4 | 38,5 | 48,5 | 26 |
Depreciation | 0,6 | 0,6 | 0,9 | 38,3 |
% | % | % | p.p. | |
Profitability of capital | 36,8 | 27,8 | 25,2 | -2,6 |
Equity capital to total assets | 78 | 82,1 | 85,5 | 3,4 |
Gross profit margin | 34 | 29,9 | 31,2 | 1,3 |
EBITDA Margin | 35,6 | 31,1 | 31,2 | 0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 57 | 53 | 46 | -7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane